Health

Peijia Medical Presents Early Clinical Findings of GeminiOne® TEER Device at TCT 2023

SUZHOU, China, Oct. 27, 2023 /PRNewswire/ -- Peijia Medical Limited (Peijia, (9996.HK)), a leading Chinese medical device player in transcatheter structural heart device and neurovascular device, presented its GeminiOne® TEER technology, along with the early clinical experiences of the device at ...

2023-10-27 20:00 1259

Henlius Deepens Collaboration with Intas to bring Henlius' Novel anti-PD-1 mAb Serplulimab to Europe and India

* The footprint of serplulimab now includes the United States, Europe, Southeast Asia, MENA, and India  * Intas to develop and commercialise serplulimab in Europe and India; Henlius to receive €42 million upfront payment, double-digit royalties and up to €143 million in regulatory and commerc...

2023-10-27 19:47 2201

Henlius Deepens Collaboration with Intas to bring Henlius' Novel anti-PD-1 mAb Serplulimab to Europe and India

* The footprint of serplulimab now includes the United States, Europe, Southeast Asia, MENA, and India * Intas to develop and commercialise serplulimab in Europe and India; Henlius to receive €42 million upfront payment, double-digit royalties and up to €143 million in regulatory and commerci...

2023-10-27 19:13 5518

Singapore PM Office awards Public Service Medal to Muhammed Aziz Khan

SINGAPORE, Oct. 27, 2023 /PRNewswire/ -- Chairman of Summit Group, Muhammed Aziz Khan, received the Public Service Medal (COVID-19) at the National Awards for his outstanding contribution to society during the pandemic. On behalf of the Prime Minister's Office ofSingapore, Minister for Health, Mr...

2023-10-27 17:36 1579

Meihua International Medical Technologies Co., Ltd.'s Subsidiary Officially Commences Construction of Comprehensive Medical Industrial Park in Hainan Free Trade Port Boao Hope City

YANGZHOU, China, Oct. 27, 2023 /PRNewswire/ -- Meihua International Medical Technologies Co., Ltd. ("MHUA" or the "Company") (NASDAQ: MHUA), a reputable manufacturer and provider of Class I, II and III disposable medical devices with operating subsidiaries inChina, announced today that its subsid...

2023-10-27 16:00 1269

World Stroke Day: World Stroke Organization calls for Action on Prevention as Global Stroke Mortality is Predicted to Rise by 50%

GENEVA, Oct. 27, 2023 /PRNewswire/ -- The World Stroke Organization (WSO ) is calling on governments and healthcare systems to implement recommendations on stroke prevention set out in the new WSO-Lancet Neurology Commission

2023-10-27 15:00 2312

NX Ireland Acquires GDP Certification for Company-owned Warehouse

TOKYO, Oct. 27, 2023 /PRNewswire/ -- Nippon Express (Ireland) Ltd. (hereafter "NX Ireland"), a group company of NIPPON EXPRESS HOLDINGS, INC., has received Good Distribution Practice (GDP) certification from the Irish Exporters Association (IEA), effectiveSeptember 21, for the temporary storage a...

2023-10-27 14:00 1632

Everest Medicines Announces New Drug Application Approval by the Pharmaceutical Administration Bureau of Macau for Nefecon® for the Treatment of Primary IgA Nephropathy

SHANGHAI, Oct. 27, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest," or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, announced today that the Pharmaceutical Administration Bureau of...

2023-10-27 13:45 1696

Everest Medicines Announces Poster Presentation at ASN Kidney Week on Nefecon® Chinese Patient Data and to Hold Conference Calls

SHANGHAI, Oct. 27, 2023 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the development, manufacturing and commercialization of innovative medicines and vaccines, today announced that it will make a late-breaking poster present...

2023-10-27 08:22 1792

Noted National TCM Master Inaugurates New Infinitus Research and Technology Laboratory

GUANGZHOU, China, Oct. 27, 2023 /PRNewswire/ – The unveiling ceremony for the joint laboratory, a collaboration between Infinitus and theShandong University of Traditional Chinese Medicine dedicated toXuezhuo-turbid blood research, took place at Infinitus Plaza. The event drew attention from over...

2023-10-27 08:00 1611

A large international study of migraine reveals new biological pathways for treatment

REYKJAVIK, Iceland, Oct. 26, 2023 /PRNewswire/ -- A large international study led by deCODE Genetics on the genetics of migraine provides novel insights into the biology of migraine enabling detection of rare variants protecting against migraine, opening an avenue for potential development of nov...

2023-10-26 23:00 1745

Chime Biologics and Hope Medicine Enter Manufacturing Agreement to Speed up the Launch of First-in-class Antibody Drug HMI-115 Targeting Endometriosis and Androgenic Alopecia

* Chime Biologics to support the late-stage clinical study and to provide global commercial manufacturing services forHope Medicine's first-in-class monoclonal antibody drug, HMI-115. * The first-in-class mAb will benefit endometriosis and androgenetic alopecia patients. SHANGHAI, Oct. 26, 20...

2023-10-26 22:49 1171

GLOBAL SURVEY IDENTIFIES COST OF LIVING, LONELINESS, TECHNOLOGY, CLIMATE CONCERNS DEEPENING

Global poll sampling 50,000 people from 23 countries highlights increasing discontent across a range of issues RIYADH, Saudi Arabia, Oct. 26, 2023 /PRNewswire/ -- A global survey commissioned by non-profit Future Investment Initiative (FII) Institute, in partnership with Accenture is released to...

2023-10-26 22:28 2388

Lunit Participates in Saudi Vision 2030 Healthcare Sandbox, Accelerating Saudi Arabia's Healthcare Transformation

* Memorandum of Understanding to be inked between Lunit and Seha Virtual Hospital, marking a new era inSaudi Arabia's healthcare innovation movement SEOUL, South Korea, Oct. 26, 2023 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and th...

2023-10-26 21:00 1129

ZEISS continues to expand its clinical workflows and digital portfolio, presenting new tools and solutions at AAO 2023

* ZEISS CT LUCIA 621P is now available for calculation on the ZEISS AI IOL Calculator. * New ZEISS PROSPARA digital marketing software within the ZEISS Corneal Refractive Workflow helps enhance online visibility for refractive practices. * ZEISS VISULAS yag therapeutic laser receives 510k cl...

2023-10-26 21:00 1312

Clarity and PSI kick off SAR-bisPSMA Phase III

SYDNEY, Oct. 26, 2023 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for children and adults with cancer, and PSI CRO AG ("PSI"), a global contract rese...

2023-10-26 21:00 1112

YS Biopharma Announces Receipt of Nasdaq Notice

GAITHERSBURG, Md., Oct. 26, 2023 /PRNewswire/ -- YS Biopharma Co., Ltd. (NASDAQ: YS) ("YS Biopharma" or the "Company"), a global biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious disea...

2023-10-26 20:30 3078

HanAll Biopharma Reports Third Quarter 2023 Financial Results and Provides a Business Update

* Sales recorded KRW 33 billion in Q3 2023, an 11 percent increase from the same period in 2022, due to the sustained growth of major products. * 'HL161ANS', HanAll's second anti-FcRn antibody, demonstrated best-in-class potential through the initial outcome of Phase 1 study. * 'HL192', a Nu...

2023-10-26 19:00 1290

Fapon, LASCCO, Abionic Formed Strategic Collaboration for PSP Sepsis Diagnosis in China

LAUSANNE, Switzerland, Oct. 26, 2023 /PRNewswire/ -- Fapon, a leading life sciences company, entered into a strategic cooperation agreement with two Swiss biotech companies LASCCO SA and Abionic SA, that granted Fapon an exclusive license to utilize the pancreatic stone protein (PSP) biomarker fo...

2023-10-26 18:33 1595

Biosyngen's BST02, the World's First TIL Therapy for Liver Cancer, is Granted an IND Approval by FDA

SINGAPORE, Oct. 26, 2023 /PRNewswire/ -- On October 26, 2023, Biosyngen's TIL therapy BST02 for liver cancer was granted an approval for clinical trial by the US FDA. BST02, a breakthrough product in the field of cell and gene therapy, represents the world's first TIL therapy designed for the tre...

2023-10-26 18:18 1856
1 ... 66676869707172 ... 813

Week's Top Stories